SIAH2 protein expression is inversely correlated with the ER status and outcome to tamoxifen therapy in metastatic breast cancer patients

被引：1
|
作者：
van der Willik, K. D.
Timmermans, M. M.
Look, M. P.
Reijm, E. A.
van Deurzen, C. H. M.
den Bakker, M. A.
Westenend, P. J.
Martens, J. W. M.
Berns, E. M. J. J.
Jansen, M. P. H. M.
机构：
[1] Erasmus MC, Inst Canc, Rotterdam, Zuid Holland, Netherlands
[2] Maasstad Hosp, Rotterdam, Zuid Holland, Netherlands
[3] Pathol Lab, Dordrecht, Zuid Holland, Netherlands
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-08-51
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] SIAH2 protein expression is inversely correlated with the ER status and outcome to tamoxifen therapy in metastatic breast cancer patients
    van der Willik, K. D.
    Timmermans, M. M.
    Look, M. P.
    Reijm, E. A.
    van Deurzen, C. H. M.
    den Bakker, M. A.
    Westenend, P. J.
    Martens, J. W. M.
    Berns, E. M. J. J.
    Jansen, M. P. H. M.
    CANCER RESEARCH, 2016, 76
  • [2] SIAH2 protein expression in breast cancer is inversely related with ER status and outcome to tamoxifen therapy
    van der Willik, Kimberly D.
    Timmermans, Mieke M.
    van Deurzen, Carolien H. M.
    Look, Maxime P.
    Reijm, Esther A.
    van Zundert, Wendy J. H. P.
    Foekens, Renee
    Trapman-Jansen, Anita M. A. C.
    den Bakker, Michael A.
    Westenend, Pieter J.
    Martens, John W. M.
    Berns, Els M. J. J.
    Jansen, Maurice P. H. M.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (02): : 270 - 284
  • [3] Low SIAH2 expression in breast cancer is associated with resistance to endocrine therapy
    Jansen, M. P. H. M.
    Dorssers, L. C. J.
    Ritstier, K.
    Foekens, J. A.
    van Staveren, I. L.
    Helleman, J.
    Look, M. P.
    Sieuwerts, A. M.
    Klijn, J. G. M.
    Berns, R. M. J. J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 184 - 185
  • [4] High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer
    Reijm, E. A.
    Timmermans, A. M.
    Look, M. P.
    Meijer-van Gelder, M. E.
    Stobbe, C. K.
    van Deurzen, C. H. M.
    Martens, J. W. M.
    Sleijfer, S.
    Foekens, J. A.
    Berns, P. M. J. J.
    Jansen, M. P. H. M.
    ANNALS OF ONCOLOGY, 2014, 25 (11) : 2185 - 2190
  • [5] Seven In Absentia Homolog 2 (SIAH2) downregulation is associated with tamoxifen resistance in MCF-7 breast cancer cells
    Interiano, Rodrigo B.
    Yang, Jun
    Harris, Adrian L.
    Davidoff, Andrew M.
    JOURNAL OF SURGICAL RESEARCH, 2014, 190 (01) : 203 - 209
  • [6] TAMOXIFEN THERAPY IN PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER
    PRITCHARD, KI
    THOMSON, DB
    MYERS, RE
    SUTHERLAND, DJA
    MOBBS, BG
    MEAKIN, JW
    CANCER TREATMENT REPORTS, 1980, 64 (6-7): : 787 - 796
  • [7] ER/PR STATUS IN BREAST CANCER HISTOLOGICAL SPECIMEN AND OUTCOME OF TAMOXIFEN BLANKET THERAPY- AN OVERALL PROTECTION IN PATIENTS OF DEVELOPING COUNTRIES
    Sharma, M.
    Sharma, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1045 - 1046
  • [8] SIAH2 expression predicts chemoresistance and poor clinical outcomes in patients with epithelial ovarian cancer
    Qiu, Jin
    Geng, Yingchun
    Meng, Fanling
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (08): : 8432 - 8439
  • [9] Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer
    Jansen, Maurice P. H. M.
    Ruigrok-Ritstier, Kirsten
    Dorssers, Lambert C. J.
    van Staveren, Iris L.
    Look, Maxime P.
    Meijer-van Gelder, Marion E.
    Sieuwerts, Anieta M.
    Helleman, Jozien
    Sleijfer, Stefan
    Klijn, Jan G. M.
    Foekens, John A.
    Berns, Els M. J. J.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (02) : 263 - 271
  • [10] Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer
    Maurice P. H. M. Jansen
    Kirsten Ruigrok-Ritstier
    Lambert C. J. Dorssers
    Iris L. van Staveren
    Maxime P. Look
    Marion E. Meijer-van Gelder
    Anieta M. Sieuwerts
    Jozien Helleman
    Stefan Sleijfer
    Jan G. M. Klijn
    John A. Foekens
    Els M. J. J. Berns
    Breast Cancer Research and Treatment, 2009, 116 : 263 - 271
12345